loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; NSC 107124, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 19685-09-7, (s)-10-hydroxycamptothecin, Hydroxycamptothecin, 10-hydroxycamptothecine, 10-hydroxy camptothecin, Hydroxycamptothecine
Molecular Formula
C20H16N2O5
Molecular Weight
364.4  g/mol
InChI Key
HAWSQZCWOQZXHI-FQEVSTJZSA-N
FDA UNII
9Z01632KRV

10-hydroxycamptothecin is a natural product found in Nothapodytes nimmoniana, Camptotheca acuminata, and Fusarium solani with data available.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
2.1.2 InChI
InChI=1S/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1
2.1.3 InChI Key
HAWSQZCWOQZXHI-FQEVSTJZSA-N
2.1.4 Canonical SMILES
CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O
2.1.5 Isomeric SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O
2.2 Other Identifiers
2.2.1 UNII
9Z01632KRV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 10-hydroxycamptothecine

2.3.2 Depositor-Supplied Synonyms

1. 19685-09-7

2. (s)-10-hydroxycamptothecin

3. Hydroxycamptothecin

4. 10-hydroxycamptothecine

5. 10-hydroxy Camptothecin

6. Hydroxycamptothecine

7. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione

8. Camptothecin, Hydroxy-

9. 10-hcpt

10. 10-hydroxy-camptothecin

11. (4s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione

12. Camptothecine, 10-hydroxy-

13. Irinotecan Related Compound A

14. Nsc107124

15. Nsc-107124

16. Chembl273862

17. Chebi:81395

18. 9z01632krv

19. Mfcd02093100

20. (+)-(s)-10-hydroxycamptothecin

21. (s)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h)-dione

22. Camptothecin, 10-hydroxy-

23. (20s)-4-ethyl-4,9-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione

24. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione ((s)-10-hydroxycamptothecin)

25. Nsc 107124

26. (s)-10-hydroxycamptothecin Hydrate

27. Unii-9z01632krv

28. (20s)-10-hydroxycamptothecin

29. Camptothecin, 10-hydroxy

30. 10-hydroxy-cpt

31. Spectrum_001639

32. Specplus_000763

33. Spectrum2_001660

34. Spectrum3_001621

35. Spectrum4_001815

36. Spectrum5_000549

37. Ethyl(dihydroxy)[?]dione

38. Schembl25875

39. Bspbio_003281

40. Kbiogr_002454

41. Kbioss_002119

42. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 4-ethyl-4,9-dihydroxy-, Hydrate, (s)-

43. Divk1c_006859

44. Spectrum1504123

45. Spbio_001819

46. Kbio1_001803

47. Kbio2_002119

48. Kbio2_004687

49. Kbio2_007255

50. Kbio3_002501

51. Dtxsid00941444

52. Ex-a988

53. Bcp01385

54. Hy-n0095

55. Zinc3979155

56. (+)-10-hydroxycamptothecin

57. Bdbm50008922

58. Ccg-38770

59. S2423

60. S3898

61. Akos015919293

62. Ac-5502

63. Bcp9000058

64. Cs-5193

65. Db12385

66. 10-hydroxycamptothecin [who-dd]

67. Ncgc00095986-01

68. Ncgc00095986-02

69. Ncgc00095986-03

70. Ncgc00095986-04

71. Ncgc00178165-01

72. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione-,4-ethyl-4,9-dihydroxy-, (s)-

73. Ac-13221

74. As-13196

75. Nci60_000173

76. Sy010687

77. H1463

78. N2591

79. 85h097

80. A25382

81. C17939

82. Irinotecan Related Compound A [usp-rs]

83. Sr-05000002620

84. Q-100241

85. Sr-05000002620-1

86. Brd-k63784565-001-02-1

87. Brd-k63784565-001-03-9

88. Q27155328

89. 4-ethyl-4,9-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione

90. (19s)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

91. (alphas)-alpha,2-dihydroxy-alpha-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinoline-7-acetic Acid 7,8-lactone

92. (s)-10-hydroxycamptothecin;-;(+/-)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione

93. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3 Inverted Exclamation Mark ,4 Inverted Exclamation Mark :6,7]indolizino[1,2-b]quinoline-3,14-(4h,12h)-dione

94. (s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4h,12h)-dione

95. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 4-ethyl-4,9-dihydroxy-, (4s)-

96. 1h-pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione-,4-ethyl-4,9-dihydroxy-, (s)-

97. 4-ethyl-4,10-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione

98. 4-ethyl-4,9-dihydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (10-hydroxycamptothecin)

2.3.3 Other Synonyms

1. Hcpt

2. Hydroxycamptothecin

3. Hydroxycamptothecine

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 364.4 g/mol
Molecular Formula C20H16N2O5
XLogP30.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count1
Exact Mass364.10592162 g/mol
Monoisotopic Mass364.10592162 g/mol
Topological Polar Surface Area100 Ų
Heavy Atom Count27
Formal Charge0
Complexity774
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents, Phytogenic

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)


Post Enquiry
POST ENQUIRY